Gabapentin successfully manages chronic unexplained irritability in children with severe neurologic impairment
- PMID: 17272610
- DOI: 10.1542/peds.2006-1609
Gabapentin successfully manages chronic unexplained irritability in children with severe neurologic impairment
Abstract
Neurologically impaired children have an increased frequency of recurrent pain and irritability that persist in some despite comprehensive evaluation and management of possible pain sources. We hypothesized that visceral hyperalgesia was a source of chronic unexplained irritability and report the outcome of gabapentin treatment in 9 severely neurologically impaired children. Caregivers reported marked improvement after treatment ranging from 3 months to 3 years. Nystagmus in 1 child was the only noted adverse effect. Visceral hyperalgesia may be a source of unexplained irritability in the neurologically impaired child. Symptoms may improve with gabapentin treatment.
Similar articles
-
Gabapentin therapy for pain and irritability in a neurologically impaired infant.Pharmacotherapy. 2009 Aug;29(8):997-1001. doi: 10.1592/phco.29.8.997. Pharmacotherapy. 2009. PMID: 19637954
-
Gabapentin for management of recurrent pain in 22 nonverbal children with severe neurological impairment: a retrospective analysis.J Palliat Med. 2015 May;18(5):453-6. doi: 10.1089/jpm.2014.0359. Epub 2015 Feb 6. J Palliat Med. 2015. PMID: 25658145
-
Experience with gabapentin for neuropathic pain in adolescents: report of five cases.Paediatr Anaesth. 2006 Mar;16(3):325-9. doi: 10.1111/j.1460-9592.2005.01687.x. Paediatr Anaesth. 2006. PMID: 16490100
-
Gabapentin for pain: balancing benefit and harm.Am Fam Physician. 2006 Feb 1;73(3):435. Am Fam Physician. 2006. PMID: 16477890 Review. No abstract available.
-
Therapeutic management of chronic neuropathic pain: an examination of pharmacologic treatment.Ann N Y Acad Sci. 2006 Nov;1088:164-86. doi: 10.1196/annals.1366.016. Ann N Y Acad Sci. 2006. PMID: 17192564 Review.
Cited by
-
Managing challenging pain and irritability in OSTM1 mutation-related infantile malignant osteopetrosis.BMJ Case Rep. 2021 May 19;14(5):e242498. doi: 10.1136/bcr-2021-242498. BMJ Case Rep. 2021. PMID: 34011644 Free PMC article.
-
Does Gabapentin Have A Role in the Improvement of Feeding Resistance in Infants?Adv Biomed Res. 2024 Jul 29;13:61. doi: 10.4103/abr.abr_346_22. eCollection 2024. Adv Biomed Res. 2024. PMID: 39411693 Free PMC article.
-
Gabapentin Use for Hospitalized Neonates.Pediatr Neurol. 2019 Aug;97:64-70. doi: 10.1016/j.pediatrneurol.2019.02.012. Epub 2019 Feb 21. Pediatr Neurol. 2019. PMID: 30922771 Free PMC article.
-
Relevance of Potential Contributing Factors for the Development and Maintenance of Irritability of Unknown Origin in Pediatric Palliative Care.Children (Basel). 2023 Oct 24;10(11):1726. doi: 10.3390/children10111726. Children (Basel). 2023. PMID: 38002817 Free PMC article.
-
Pediatric Palliative Care for Children with Progressive Non-Malignant Diseases.Children (Basel). 2018 Feb 20;5(2):28. doi: 10.3390/children5020028. Children (Basel). 2018. PMID: 29461497 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical